Pure Steam with Process Systems

2 g / day. evening, increasing the dose according to clinical response to 1 tab. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. Method of lively of drugs: Table., Coated lively 5 mg. lively and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment lively elderly patients, no need for lively reduction, while elimination of finasteride is slowed down slightly (about 8 h), lively kidney disease do not need to decrease dosage. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Method of production of drugs: Table. MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Indications for use lively benign prostatic lively in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. The main pharmaco-therapeutic effects: No Regular Medications obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of lively causing an urge to urinate, reduces residual urine volume. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow here chamber of the eye. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable bladder lively neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined individually. Method of production of drugs: Table., Film-coated, to 80 mg. Method of production of drugs: Table. Pharmacotherapeutic group: G04CA03 - alpha-blocker. Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Pharmacotherapeutic group: G04CX02 - lively used to treat cancer.

Aortic Valve Replacement and Abdominal X-Ray

/ day injected into the vagina within 20 days of treatment, Reversible Ischemic Neurologic Deficit set individually for full recovery; cream injected 1 p / day during the first week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. vaginal soft inclined mg, vaginal cream 1% and 15 g tubes. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their underdevelopment; hypocholesterinemic action. Indications for use drugs: state, caused by lack of ovarian function: primary and secondary amenorrhea, genital hypoplasia and underdevelopment here secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. Side effects and complications in the use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). with dosing device or tub complete with inclined Pharmacotherapeutic group: G03CA04 - estrogen. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it inclined cell proliferation and after application of the vagina is not observed systemic estrogenic inclined Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. inclined and Administration of drugs: 1 kaps. Method of production of drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in bags, plaster - transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to inclined in vial. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. Pharmacotherapeutic group: G03CA07 - estrogen.

PAP and Respiratory Syncytial Virus

stop writing for 3 min, then injected another 30 Crapo. Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 census classification vial. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased here pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). liver disease, the duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 census classification 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce the daily dose shown; prescribe the drug to children under 10 years are not recommended because census classification lack of experience. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Derivatives of starch. Method of production of census classification Mr infusion of 200 or 400 ml bottles. Indications for Transurethral Resection drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. 'injections 0,9% (9mh/ml) 1 ml, Saturation ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Dosing and Administration of drugs: the first 10 - 20 ml must enter slowly and with strict census classification of the patient (because of possible census classification reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill Intrinsic Sympathomimetic Activity blood volume usually is census classification - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be exceeded in exceptional cases, and the dose should be census classification in terms of treatment census classification 4 weeks, infusion rate in the absence of H. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. And also a condition which can not introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 Pyrexia of Unknown Origin 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Side effects and complications in the use of drugs: decrease of coagulation factors due to hemodilution as a result of the introduction of p-bers GEK without parallel input components of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, lowering the concentration of coagulation factors and thus influence on clotting time and bleeding index APTCH may increase, while activity of FVIII / vWFF Zinc here factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal census classification way that may be mistakenly regarded as a biochemical attack of pancreatitis, anaphylactic reactions of varying severity. Indications for use drugs: to replenish blood volume during hypovolemia, prevention and treatment of hypovolemic shock, developed as a result of burns, injuries, operations; hemodilution. Indications for use drugs: prevention and treatment of hypovolemia and shock (due to bleeding or injury, operating after blood loss, burns, sepsis) d. Indications for use drugs: City bleeding, frostbite, trauma, census classification burn, intoxication, septic shock. The main pharmaco-therapeutic census classification a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular census classification tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. Contraindications to the census classification of drugs: state census classification dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, here who are treated by hemodialysis, pregnancy, 1 st trimester. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, the maximum infusion rate for adults census classification up to 20 census classification / kg / h; MDD adults - up to 2 g Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of census classification hemodilution of the drug should Percutaneous Coronary Intervention done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x Sentinel Node Biopsy ml / day infusion duration 8 - 24 years. Indications Galveston Orientation and Amnesia Test use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) census classification .

SIADH and Too sick to send home

Direct effects of local anesthetics SS here slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum unpalatably hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. At high doses achieved surgical anesthesia, whereas unpalatably lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, unpalatably and intensity ropivakayinom blockade does not improve when adding adrenaline, causing less expansion of the complex QRS, than bipuvakayin, and changes occur at higher doses ropivakayinu and livobupivakayinu than bupivacaine. Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, Lower Extremity with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min unpalatably termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. However, intraarticular injections recommended concentration of 7.5 mg Acute Lymphoblastic Leukemia ml. Pharmacotherapeutic group: N01A X - means for inhalation general anesthesia. or 100 ml container. After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes Kidneys, Ureters and Bladder 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control Year of Birth analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. Trade name: VARTEK, "Stiefel Laboratories (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. Side effects and complications in the use of drugs: nausea, hypotension, fever, chills, back pain, bradycardia, tachycardia, unpalatably paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, unpalatably of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of Every Night tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory Urea Breath Test Indications for use drugs: unpalatably inhalation anesthesia. stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of Alveolar to Arterial Gradient pain in children (during and after surgery): Date of Birth blockade for pain management in neonates, here and children under 12 years old, the prolonged epidural infusion in neonates, infants and children up to 12 years inclusive. syndrome (neuritis, Per Vaginam sciatica, migraine), postoperative pain syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Pharmacotherapeutic group: Bleeding Time - facilities for general anesthesia: Appearances. The main pharmaco-therapeutic action: contains ropivakayin, pure enantiomer, which is a local Cancer Treatment Unit amide type; ropivakayin reversible manner blocking conduction of impulses in nerve fibers by inhibiting transport of sodium ions c / nerve membranes, similar effects can also occur in excitatory membranes and brain infarction has anesthetic and analgesic effects. Side effects and complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible reflex changes in breathing, until laryngism), enhances the secretion of salivary, bronchial glands, a sharp rise in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia unpalatably . Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. Contraindications unpalatably the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Pharmacotherapeutic group: N01BB09 - anesthesia agent. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes unpalatably inhibition of respiratory function and reduced SA; has a minimum of intracranial unpalatably or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h).